Hidehisa Ohi Selected Research

Crohn Disease (Crohn's Disease)

11/2022	Adrenomedullin for biologic-resistant Crohn's disease: A randomized, double-blind, placebo-controlled phase 2a clinical trial.
2/2021	Infliximab therapy intensification based on endoscopic activity is related to suppress treatment discontinuation in patients with Crohn disease: A retrospective cohort study.
1/2019	Effect of a concomitant elemental diet with maintenance anti-tumor necrosis factor-α antibody therapy in patients with Crohn's disease: A multicenter, prospective cohort study.
5/2013	Effectiveness of concomitant enteral nutrition therapy and infliximab for maintenance treatment of Crohn's disease in adults.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hidehisa Ohi Research Topics

Disease

5	Ulcerative Colitis 11/2022 - 06/2009
4	Crohn Disease (Crohn's Disease) 11/2022 - 05/2013
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 11/2022
1	Colitis 06/2009
1	Colonic Neoplasms (Colon Cancer) 06/2009
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2003
1	Neoplasms (Cancer) 01/2002
1	Signet Ring Cell Carcinoma 01/2002

Drug/Important Bio-Agent (IBA)

3	Infliximab (Remicade)FDA Link 02/2021 - 05/2013
2	AdrenomedullinIBA 11/2022 - 01/2021
2	Indigo Carmine (Indigo Blue)IBA 02/2020 - 01/2018
1	SteroidsIBA 01/2021
1	Adalimumab (Humira)FDA Link 01/2019
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2019
1	ImmunosorbentsIBA 06/2009
1	Peptides (Polypeptides)IBA 06/2009
1	EnzymesIBA 06/2009
1	Biomarkers (Surrogate Marker)IBA 06/2009
1	MucinsIBA 01/2002

Therapy/Procedure

3	Therapeutics 02/2021 - 05/2013
1	Enteral Nutrition (Feeding, Tube) 05/2013
1	Pancreatectomy 01/2003
1	Splenectomy 01/2003